| 1 | university hospital of lausanne | | | | | | | 9 | 2.20% |
| 2 | institution university hospital of | | | | | | | 7 | 1.71% |
| 3 | partners contribution to development | | | | | | | 3 | 0.73% |
| 4 | negotiation of contracts identification | | | | | | | 3 | 0.73% |
| 5 | contribution to development of | | | | | | | 3 | 0.73% |
| 6 | creation of local startup | | | | | | | 3 | 0.73% |
| 7 | of local startup companies | | | | | | | 3 | 0.73% |
| 8 | rights negotiation of contracts | | | | | | | 3 | 0.73% |
| 9 | pharmaceuticals institution university of | | | | | | | 2 | 0.49% |
| 10 | property rights negotiation of | | | | | | | 2 | 0.49% |
| 11 | technologies available for licensing | | | | | | | 2 | 0.49% |
| 12 | local startup companies protection | | | | | | | 2 | 0.49% |
| 13 | of contracts identification of | | | | | | | 2 | 0.49% |
| 14 | startup companies protection of | | | | | | | 2 | 0.49% |
| 15 | industrial partners contribution to | | | | | | | 2 | 0.49% |
| 16 | supporting creation of local | | | | | | | 2 | 0.49% |
| 17 | contracts identification of potential | | | | | | | 2 | 0.49% |
| 18 | of business plans and | | | | | | | 2 | 0.49% |
| 19 | development of business plans | | | | | | | 2 | 0.49% |
| 20 | to development of business | | | | | | | 2 | 0.49% |
| 21 | protection of intellectual property | | | | | | | 2 | 0.49% |
| 22 | business plans and supporting | | | | | | | 2 | 0.49% |
| 23 | imaging institution university hospital | | | | | | | 2 | 0.49% |
| 24 | to find us – | | | | | | | 2 | 0.49% |
| 25 | where to find us | | | | | | | 2 | 0.49% |
| 26 | or venture with researchers | | | | | | | 1 | 0.24% |
| 27 | chuv learn more technologies | | | | | | | 1 | 0.24% |
| 28 | licensing some of the | | | | | | | 1 | 0.24% |
| 29 | for licensing some of | | | | | | | 1 | 0.24% |
| 30 | for triple negative breast | | | | | | | 1 | 0.24% |
| 31 | to engage in any | | | | | | | 1 | 0.24% |
| 32 | biotechnologypharmaceuticals institution university of | | | | | | | 1 | 0.24% |
| 33 | triple negative breast cancer | | | | | | | 1 | 0.24% |
| 34 | learn more technologies available | | | | | | | 1 | 0.24% |
| 35 | or the chuv learn | | | | | | | 1 | 0.24% |
| 36 | the chuv learn more | | | | | | | 1 | 0.24% |
| 37 | venture with researchers from | | | | | | | 1 | 0.24% |
| 38 | lausanne or the chuv | | | | | | | 1 | 0.24% |
| 39 | of lausanne or the | | | | | | | 1 | 0.24% |
| 40 | university of lausanne or | | | | | | | 1 | 0.24% |